Co-Authors
This is a "connection" page, showing publications co-authored by Johan Neyts and Dirk Jochmans.
Connection Strength
2.754
-
The path towards effective antivirals against rabies. Vaccine. 2019 08 02; 37(33):4660-4662.
Score: 0.747
-
A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE. J Virol Methods. 2012 Aug; 183(2):176-9.
Score: 0.505
-
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents. Antiviral Res. 2021 08; 192:105122.
Score: 0.238
-
ALG-097111, a potent and selective SARS-CoV-2 3-chymotrypsin-like cysteine protease inhibitor exhibits in vivo efficacy in a Syrian Hamster model. Biochem Biophys Res Commun. 2021 05 28; 555:134-139.
Score: 0.234
-
Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase. Antiviral Res. 2021 09; 193:105142.
Score: 0.060
-
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues. Antiviral Res. 2021 09; 193:105127.
Score: 0.060
-
In vitro activity of itraconazole against SARS-CoV-2. J Med Virol. 2021 Jul; 93(7):4454-4460.
Score: 0.060
-
Corrigendum to "itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens". EBioMedicine. 2021 Jul; 69:103454.
Score: 0.060
-
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient one-step synthesis and functionalization as influenza polymerase PA-PB1 interaction disruptors. Eur J Med Chem. 2021 Oct 05; 221:113494.
Score: 0.059
-
Design, Synthesis, and Biological Evaluation of Peptidomimetic Aldehydes as Broad-Spectrum Inhibitors against Enterovirus and SARS-CoV-2. J Med Chem. 2022 02 24; 65(4):2794-2808.
Score: 0.059
-
Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial. EBioMedicine. 2021 Apr; 66:103288.
Score: 0.058
-
Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nat Genet. 2021 04; 53(4):435-444.
Score: 0.058
-
Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19. J Phys Chem Lett. 2021 Feb 25; 12(7):1793-1802.
Score: 0.058
-
STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat Commun. 2020 11 17; 11(1):5838.
Score: 0.057
-
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nat Chem Biol. 2021 02; 17(2):222-228.
Score: 0.057
-
Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry. Antiviral Res. 2020 10; 182:104924.
Score: 0.056
-
Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones. ACS Infect Dis. 2018 04 13; 4(4):605-619.
Score: 0.047
-
Mannitol treatment is not effective in therapy of rabies virus infection in mice. Vaccine. 2019 08 02; 37(33):4710-4714.
Score: 0.047
-
Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection. Antiviral Res. 2018 01; 149:113-117.
Score: 0.046
-
Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1. Antiviral Res. 2017 08; 144:216-222.
Score: 0.045
-
A novel kindred with inherited STAT2 deficiency and severe viral illness. J Allergy Clin Immunol. 2017 06; 139(6):1995-1997.e9.
Score: 0.044
-
Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity. Bioorg Med Chem Lett. 2015 Aug 01; 25(15):2923-6.
Score: 0.039
-
Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother. 2014 Aug; 58(8):4875-84.
Score: 0.036
-
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother. 2008 Apr; 52(4):1302-17.
Score: 0.023